Trial intelligence / Profile preview

Targeted Injection of Nerves to the Knee

NCT07444827Phase 4Not yet recruiting

Sponsor
Duke University
Start
Jan 2027
Primary completion
Jul 2027
Modality
Small Molecules
01

Overview

A Phase 4 trial of chloroprocaine, sponsored by Duke University. Planned start Jan 2027; status: not yet recruiting.

02

Drugs

chloroprocaine

Beyond the preview

Go deeper on NCT07444827.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07444827.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call